FORMIGARO, Luca
 Distribuzione geografica
Continente #
NA - Nord America 1.599
EU - Europa 512
AS - Asia 340
OC - Oceania 3
Totale 2.454
Nazione #
US - Stati Uniti d'America 1.595
CN - Cina 176
DE - Germania 127
IT - Italia 116
TR - Turchia 85
SG - Singapore 65
GB - Regno Unito 61
UA - Ucraina 55
SE - Svezia 49
BE - Belgio 31
FI - Finlandia 21
RU - Federazione Russa 12
FR - Francia 11
CZ - Repubblica Ceca 9
PL - Polonia 8
VN - Vietnam 5
CA - Canada 4
ID - Indonesia 4
IE - Irlanda 4
AU - Australia 3
NL - Olanda 3
LT - Lituania 2
AT - Austria 1
EE - Estonia 1
HK - Hong Kong 1
IN - India 1
IR - Iran 1
JP - Giappone 1
MK - Macedonia 1
UZ - Uzbekistan 1
Totale 2.454
Città #
Woodbridge 233
Fairfield 211
Ann Arbor 172
Chandler 118
Houston 111
Ashburn 94
Jacksonville 79
Seattle 79
Cambridge 66
Wilmington 65
Beijing 62
Singapore 59
Ferrara 52
Santa Clara 47
Nanjing 38
Izmir 34
New York 34
Brussels 31
Milan 23
Shanghai 22
Princeton 20
Addison 16
San Diego 16
Boardman 15
Munich 14
Bremen 13
Shenyang 11
Brno 9
Los Angeles 8
Nanchang 8
Warsaw 8
Frankfurt am Main 7
Falls Church 6
London 6
Tianjin 6
Changsha 5
Dong Ket 5
Helsinki 5
Jinan 5
Augusta 4
Des Moines 4
Dublin 4
Hebei 4
Jakarta 4
Ningbo 4
Illasi 3
Jiaxing 3
Norwalk 3
Hangzhou 2
Kunming 2
Mountain View 2
Orange 2
Ottawa 2
Redwood City 2
Toronto 2
Acton 1
Anzola Dell'emilia 1
Ardabil 1
Berlin 1
Central 1
Colico 1
Edinburgh 1
Lanzhou 1
Leawood 1
Melbourne 1
Perth 1
Pescara 1
Redmond 1
Rome 1
Simi Valley 1
Stockholm 1
Tallinn 1
Trieste 1
Velp 1
Venezia 1
Vienna 1
Washington 1
Zhengzhou 1
Totale 1.883
Nome #
In CLL, comorbidities and the complex karyotype are associated with an inferior outcome independently of CLL-IPI 189
Diagnostic work-up for clinical and prognostic assessment of acute leukaemia 164
Genetic subclonal complexity and miR125a-5p down-regulation identify a subset of patients with inferior outcome in low-risk CLL patients 136
Employment of Oligodeoxynucleotide plus Interleukin-2 Improves Cytogenetic Analysis in SplenicMarginal Zone Lymphoma 136
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia: Clinical and biologic correlations. 132
Identifying High-Risk Chronic Lymphocytic Leukemia: A Pathogenesis-Oriented Appraisal of Prognostic and Predictive Factors in Patients Treated with Chemotherapy with or without Immunotherapy 132
Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: Clinical and biological correlations 132
In chronic lymphocytic leukaemia with complex karyotype, major structural abnormalities identify a subset of patients with inferior outcome and distinct biological characteristics 131
CYTOGENETIC ABERRATIONS IN THE CD38 POSITIVE FRACTION OF CD38 NEGATIVE CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS: A MARKER OF AGGRESSIVENESS? 130
An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness 126
An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness 125
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia: Clinical and biologic correlations 119
Delirium in acute promyelocytic leukemia patients: two case reports. 117
Erratum to: Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: clinical and biological correlations (J Hematol Oncol. (2016) 9 (88) DOI:10.1186/s13045-016-0320-z) 113
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS IN A PATIENT WITH RELAPSED CHRONIC LYMPHOCYTIC LEUKEMIA TREATED WITH IBRUTINIB 107
“Hemophagocytic Lymphohistiocytosis after EBV reactivation and ibrutinib treatment in relapsed/refractory Chronic Lymphocytic Leukemia” 102
Hemophagocytic Lymphohistiocytosis in a Patient with Relapsed Chronic Lymphocytic Leukemia Treated with Ibrutinib 95
Identifying High-Risk Chronic Lymphocytic Leukemia: A Reappraisal of the Impact of Prognostic and Predictive Factors 94
null 88
null 64
Diagnostic workup for clinical and prognostic assessment of acute leukemia. 33
Response to ibrutinib of refractory life-threatening autoimmune hemolytic anemia occurring in a relapsed chronic lymphocytic leukemia patient with 17p deletion 22
Totale 2.487
Categoria #
all - tutte 11.472
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.472


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020318 0 0 0 0 38 56 56 42 53 40 20 13
2020/2021389 18 32 19 34 14 37 18 35 8 71 73 30
2021/2022267 32 15 8 8 13 15 30 10 9 24 33 70
2022/2023274 28 27 17 36 46 36 24 18 24 0 13 5
2023/2024133 11 13 5 3 3 43 8 8 2 2 1 34
2024/2025184 14 11 45 39 75 0 0 0 0 0 0 0
Totale 2.487